Provided by Tiger Trade Technology Pte. Ltd.

MediWound

13.40
+0.05000.37%
Post-market: 13.400.00000.00%16:10 EDT
Volume:81.94K
Turnover:1.10M
Market Cap:173.00M
PE:-8.57
High:13.49
Open:13.42
Low:13.30
Close:13.35
52wk High:20.03
52wk Low:12.52
Shares:12.91M
Float Shares:8.75M
Volume Ratio:0.91
T/O Rate:0.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5630
EPS(LYR):-2.0990
ROE:-72.37%
ROA:-28.59%
PB:4.85
PE(LYR):-6.38

Loading ...

Josh Jennings Reiterates Buy on MediWound, Citing EscharEx as Key Growth Driver and DSMB Phase III VALUE Trial Review as Major De‑Risking Milestone

TIPRANKS
·
Sep 17

MediWound DSMB Sees no Safety Issues, Backs EscharEx Phase III Venous Leg Ulcer Trial Continuing Unchanged

Reuters
·
Sep 14

Mediwound - Dsmb Did not Identify Safety Concerns in Pre-Specified Review

THOMSON REUTERS
·
Sep 14

Mediwound - Interim Assessment and Enrollment Completion on Track for End of Q1 2027

THOMSON REUTERS
·
Sep 14

Independent Dsmb Recommends Mediwound’s Escharex® Phase Iii Value Study Continue Without Modification

THOMSON REUTERS
·
Sep 14

MediWound Director Samuel Rubinstein Reports Disposal of 525 Common Shares Worth $6,678

Reuters
·
Sep 03

MediWound CEO Joins H.C. Wainwright Global Investment Conference Fireside Chat

Reuters
·
Sep 02

MediWound COO, Chief Commercial Officer Shmuel Hess Sells 5,823 Shares for $75,097.55

Reuters
·
Aug 29

MediWound Earnings Call Balances Growth Plans With Strain

TIPRANKS
·
Aug 21

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Capricor Therapeutics (CAPR)

TIPRANKS
·
Aug 16

MediWound (MDWD) Stock Faces Cash Burn As Revenue Slips

Simply Wall St.
·
Aug 15

MediWound Price Target Cut to $30.00/Share from $32.00 by Oppenheimer

Dow Jones
·
Aug 15

Lifeward Ltd Q2 Revenue up 16% on Higher ReWalk Personal Exoskeleton Sales

Reuters
·
Aug 14

Oppenheimer Remains a Buy on Mediwound (MDWD)

TIPRANKS
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Relay Therapeutics (RLAY)

TIPRANKS
·
Aug 14

Singapore's Medtecs HY Profit Jumps on Higher Revenue, Lower Taxes

Reuters
·
Aug 14

Analysts Conflicted on These Healthcare Names: Fate Therapeutics (FATE) and Mediwound (MDWD)

TIPRANKS
·
Aug 14

Mediwound Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Israel's MediWound Beats Q2 Revenue Estimates, Reaffirms 2026 Guidance

Reuters
·
Aug 13

MediWound Posts Investor Presentation on Enzymatic Burn and Chronic-Wound Therapies NexoBrid, EscharEx

Reuters
·
Aug 13